文献速递分子诊断临床血液与体液

慢性淋巴细胞白血病突变特征分析揭示基因组模式与预后意义

Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications.
PubMed 文献 · Am J Clin Pathol · 2025-01-01

该研究对2013至2022年间209例慢性淋巴细胞白血病(CLL)样本进行OncoPanel测序,提取新发突变特征并与临床及遗传数据关联。多数体细胞突变位于14号染色体ADAM6区域,主导突变为C到T单碱基替换,发现两个与IGHV超突变/未突变状态相关的新发SBS特征,且13.3%样本携带SBS42特征提示卤代烷暴露关联。

要点

  • 多数体细胞突变位于14号染色体ADAM6区域。
  • 两个新发SBS特征分别与IGHV超突变和未突变状态相关。
  • 13.3%样本携带SBS42特征,提示职业性卤代烷暴露可能为CLL环境风险因素。

核心结论

  • 新发SBS特征与IGHV状态相关,揭示传统风险分层方法未能反映的疾病异质性。
  • 首次提出卤代烷暴露特征与CLL之间的新关联。

研究设计与样本

  • 回顾性分析2013至2022年经多版本OncoPanel测序的209例CLL样本。
  • 获取下一代测序流程产生的所有变异,排除可能种系多态性后生成突变特征。
  • 提取新发突变特征并与临床及遗传数据关联分析。

主要发现

  • 多数体细胞突变位于14号染色体ADAM6区域。
  • 体细胞突变特征分析显示以C到T单碱基替换为主的内源性突变过程。
  • 鉴定出两个新发SBS特征,均以SBS84特征加权,分别与体细胞超突变和未突变状态相关,伴显著疾病异质性。
  • 13.3%的队列呈现SBS42特征,提示与职业性卤代烷暴露相关。

关键数值与推荐

  • 队列共209例CLL样本。
  • 13.3%的样本呈现SBS42特征。

临床怎么用

  • 突变特征分析可补充IGHV状态信息,帮助识别CLL疾病异质性。
  • SBS42特征提示需关注患者职业性卤代烷暴露史作为潜在环境风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the mutational signature(s) for patients with diagnosed chronic lymphocytic leukemia (CLL) and their correlation with clinical and genetic classifications. METHODS: All CLL samples sequenced on several versions of OncoPanel, from 2013 to 2022, were examined (n = 209). All variants produced by the next-generation sequencing pipeline, before review, were obtained for these samples. After the exclusion of likely germline polymorphisms, mutational signatures were generated. De novo mutational signatures were extracted and correlated with clinical and genetic data. RESULTS: Most somatic mutations were found in chromosome 14 (within ADAM6). Somatic mutation signatures analysis revealed a prominent endogenous mutational process, which predominantly led to C-to-T single base substitutions (SBSs). Two novel de novo SBS signatures were identified, weighted by the SBS84 signature, that correlated with somatically hypermutated and unmutated status, respectively, with significant disease heterogeneity. A notable 13.3% of the cohort exhibited the SBS42 signature, suggesting a link to occupational haloalkane exposure, representing a potential new environmental risk factor for CLL. CONCLUSIONS: The de novo SBS signatures were identified as being associated with IGHV status, highlighting significant disease heterogeneity that belies the more categorical and limited traditional risk stratification methods. Also, a novel association was made between haloalkane exposure signature and CLL.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. AlJabban A, Azevedo RS, Antel K, et al. Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications. Am J Clin Pathol. 2025. PMID: 40814292. doi:10.1093/ajcp/aqaf059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。